Plasmodium falciparum malaria 恶性疟疾 ; 恶性疟
plasmodium falciparum infected 恶性疟原虫感染
plasmodium falciparum pf 恶性疟原虫
plasmodium falciparum merozoite 疟原虫裂殖子
plasmodium falciparum chimeric protein 恶性疟原虫融合抗原
EBA-175 of Plasmodium falciparum 恶性疟原虫EBA
plasmodium falciparum-infected erythrocytes 红细胞感染恶性疟原虫
AIM: To assess the sensitivity of Plasmodium falciparum to antimalarials.
目的：了解恶性疟原虫对各种常用抗疟药的敏感性，以指导合理应用抗疟药。
参考来源 - 我国恶性疟原虫对抗疟药敏感性的现状Objective:1. To modify coding sequence of a single chain antibody(2A10) against circumsporozoite protein(CSP) of Plasmodium falciparum and construct fusion gene Cecrop-m2A10.2.
目的:1.对鼠源性恶性疟原虫环子孢子蛋白单链抗体2A10基因进行改造,构建融合基因Cecrop-m2A10。
参考来源 - Cecrop·2,447,543篇论文数据，部分数据来源于NoteExpress
以上来源于: WordNet
Plasmodium falciparum and Plasmodium vivax are the most common.
恶性疟和间日疟最常见。
Conclusion Naphthoquine phosphate is effective for the treatment of patients with Plasmodium falciparum malaria.
结论：磷酸萘酚喹治疗恶性疟疾具有良好的效果。
Objective To explore factors influencing the results of in vitro microtest for drug sensitivity of Plasmodium falciparum (Pf).
目的探讨体外微量法测定恶性疟原虫对抗疟药敏感性的影响因素。
应用推荐